CIK 0000949858
- Non-accelerated filer
- Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Tickers
- ACHV QUIT
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 954343413
- Phone
- +1 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
Securities
- ACHV Common stock Nasdaq
- QUIT Common Shares Nasdaq
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President and CEO gave up 9,206 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, CMO gave up 4,376 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, CMO gave up 1,310 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 3,401 shares (to pay taxes)
- 4 Open-market sale EVP, CMO sold 5,650 shares at $3.17 ($17,911)
- 4 Open-market sale President and CEO sold 18,341 shares at $3.17 ($58,141)
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 2,500 shares (option exercise)
- 4 Exercise or conversion Director acquired 2,500 shares (option exercise)
- 4 Exercise or conversion Director acquired 2,500 shares (option exercise)
- 4 Exercise or conversion Director acquired 4,500 shares (option exercise)
- 4 Exercise or conversion Director acquired 2,500 shares (option exercise)
- 4 Open-market sale PAO sold 182 shares at $12.25 ($2,230)
- 4 Open-market sale EVP, CMO sold 1,250 shares at $12.25 ($15,313)
- 4 Open-market sale President and CEO sold 4,634 shares at $12.25 ($56,767)
Page 14 of 24 · 465 filings